EIF's Women's Cancer Research Fund

share / bookmark page

EIF's Women's Cancer Research Fund

EIF’s Women’s Cancer Research Fund,has helped bring about one of the most exciting and ambitious scientific projects today. It is called EIF’s Breast Cancer Biomarker Discovery Project. Led by world-class scientists, the goal is to find a blood test that will diagnose breast and other women’s cancers in the earliest stages when it can be cured.

Under the leadership and oversight of Seattle’s renowned Fred Hutchinson Cancer Research Center, EIF’s Women’s Cancer Research Fund supports a consortium of institutions which are participating in the WCRF Breast Cancer Biomarker Discovery Project. 

Scientists from the following laboratories are collaborating on an initiative that they hope will one day lead to the development of this  blood test:

EIF's Breast Cancer Biomarker Discovery Project Scientists:

Steven Carr, Ph. D.
Broad Institute of Massachusetts Institute of Technology and Harvard

Francisco J. Esteva, M.D, Ph.D.
University of Texas, M.D. Anderson Cancer Center

Peter W. Laird, Ph.D.
University of Southern California, Norris Comprehensive Cancer Center

Amanda G. Paulovich, M.D., Ph.D.
Fred Hutchinson Cancer Research Center

Peggy L. Porter, M.D.
Fred Hutchinson Cancer Research Center

Aysegul A. Sahin, M.D.
University of Texas M.D. Anderson Cancer Center

Richard D. Smith, Ph.D.
Battelle/Pacific Northwest National Laboratory

Pei Wang, Ph.D.
Fred Hutchinson Cancer Research Center

 

EIF's Breast Cancer Biomarker Discovery Project Steering Committee:

Eric S. Lander, Ph.D.
Broad Institute of Massachusetts Institute of Technology and Harvard

Gabriel N. Hortobagyi, M.D., F.A.C.P.
University of Texas M. D. Anderson Cancer Center

Lee H. Hartwell, Ph.D., Nobel laureate
Fred Hutchinson Cancer Research Center

 

The Project receives oversight from the following clinical advisors and oversight committee. 

Clinical Advisors:

Eric P. Winer, M.D.
Dana-Farber Cancer Institute

Julie R. Gralow, M.D.
University of Washington Seattle Cancer Care Alliance

 

EIF's Breast Cancer Biomarker Discovery Project Oversight Committee:

Richard D. Klausner, M.D., Chair
Chair, The Column Group

David Baltimore, Ph.D., Nobel laureate
California Institute of Technology

Joe W. Gray, Ph. D.
Lawrence Berkeley National Laboratory

C. Kent Osborne, M.D.
Breast Center Baylor College of Medicine

Lawrence D. Platt, M.D.
Center for Fetal Medicine and Women’s Ultrasound

Phillip A. Sharp, Ph.D., Nobel laureate
Center for Cancer Research, Massachusetts Institute of Technology

Ellen V. Sigal, Ph.D.
Friends of Cancer Research